Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

AZ sign

AstraZeneca’s Tagrisso gets EU lung cancer sign-off

February 4, 2016 Sales and Marketing AstraZeneca, European Commission, NSCLC, Tagrisso, non-small cell lung cancer, osimertinib

The European Commission (EC) has granted conditional marketing authorisation to AstraZeneca’s Tagrisso to treat locally advanced or metastatic non-small cell …
News
Merck image

Revenues down at MSD

February 4, 2016 Sales and Marketing MSD, financial performance, profits, revenue, sales

MSD (Merck, Sharpe and Dohme) reported a mixed bag of financial figures today, as the company announced full-year 2015 revenues …
News
pills-943764_1920

Revealed: analysts predict seven highest-earning pharma blockbusters

February 4, 2016 Sales and Marketing Gilead, OCA, Thomson Reuters, blockbusters, sales

Seven new drugs currently in development will enter the market this year – and earn sales of more than $1 …
News

Pfizer revenues down, but above expectations

February 3, 2016 Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
News
sun_pharma_logo

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
News
bms_logo_square

Europe approves BMS hep C drug for HIV and liver transplant patients

February 1, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza

The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …
News
abbvie

AbbVie posts strong Q4 results

February 1, 2016 Sales and Marketing AbbVie, Humira, Viekira Pak

AbbVie managed to meet or beat analysts’ expectations in its Q4 financial results report, with extremely strong Humira sales contributing …
News
corbett_issy

PwC appoints Issy Corbett as healthcare M&A partner

February 1, 2016 Sales and Marketing pwC

PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …
Appointment
Westminster

Ministers reject bid to revive Off Patent Drugs Bill

February 1, 2016 Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs

Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …
News
EMA inside

Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions

February 1, 2016 Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …
News
Empliciti pack shot

EMA fast-tracks BMS multiple myeloma drug

February 1, 2016 Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma

The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …
News
john_milligan_gilead_sciences

Gilead Sciences names John Milligan new CEO

January 29, 2016 Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan

Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …
Appointment
allergan

Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016 Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …
News
business_generic

Pharma: How to make mergers work

January 29, 2016 Sales and Marketing mergers and acquisitions

Pharma is no stranger to bursts of M&A activity.
Feature
Merck image

MSD gets FDA approval for hepatitis C drug Zepatier

January 29, 2016 Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C

The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …
News
The Gateway to Local Adoption Series

Latest content

Trio become latest Symbiosis commercial additions

October 12, 2026

UK immunoglobulin supply faces growing pressure, report warns

October 12, 2026

How will biomarker-led diagnostics reshape respiratory medicine?

October 11, 2026

Five Facts about COPD

October 11, 2026

“That gap between innovation and delivery was what stood out to me most”

October 11, 2026